Eric Campeau

2PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.

Dae-Hwan Kim, Duanchen Sun, William K Storck

|Jul 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer.

Rahul R Aggarwal, Michael T Schweizer, David M Nanus

Pageof 1

Frequent Collaborators

2 joint publications

Joshi J Alumkal

1 joint publications

Elisabeth I Heath

1 joint publications

Margo Snyder

1 joint publications

Dae-Hwan Kim